Page last updated: 2024-11-04

sulfinpyrazone and Coronary Thrombosis

sulfinpyrazone has been researched along with Coronary Thrombosis in 2 studies

Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.

Coronary Thrombosis: Coagulation of blood in any of the CORONARY VESSELS. The presence of a blood clot (THROMBUS) often leads to MYOCARDIAL INFARCTION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shalaev, SV1
Bokarev, IN1
Golikov, AP1
Liusov, VA1
Ptushkin, VV1
Zvereva, TV1

Reviews

1 review available for sulfinpyrazone and Coronary Thrombosis

ArticleYear
[Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
    Kardiologiia, 1989, Volume: 29, Issue:9

    Topics: Aspirin; Canada; Clinical Trials as Topic; Coronary Disease; Coronary Thrombosis; Dipyridamole; Drug

1989

Trials

1 trial available for sulfinpyrazone and Coronary Thrombosis

ArticleYear
[Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
    Kardiologiia, 1989, Volume: 29, Issue:9

    Topics: Aspirin; Canada; Clinical Trials as Topic; Coronary Disease; Coronary Thrombosis; Dipyridamole; Drug

1989

Other Studies

1 other study available for sulfinpyrazone and Coronary Thrombosis

ArticleYear
[Use of anturan in patients with ischemic heart disease with a history of acute myocardial infarction].
    Klinicheskaia meditsina, 1987, Volume: 65, Issue:10

    Topics: Coronary Disease; Coronary Thrombosis; Humans; Male; Myocardial Infarction; Platelet Aggregation; Pl

1987